Literature DB >> 20211149

Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression.

Tura C Camilli1, Ashani T Weeraratna.   

Abstract

Wnt signaling can be divided into three pathways, namely the canonical Wnt/beta-catenin pathway, and the non-canonical (or heretical) Wnt/Ca(2+) and planar cell polarity (PCP) pathways. Although the canonical Wnt/beta-catenin pathway is the best described in cancer, increasing data points to the importance of the heretical Wnt pathways in several aspects of tumor progression. The recent advances in understanding the players and mechanisms by which these Wnt pathways contribute to cancer progression have led to the identification of numerous molecules that are already, or could be considered, targets for cancer therapy. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211149      PMCID: PMC2897923          DOI: 10.1016/j.bcp.2010.03.002

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  217 in total

Review 1.  Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs.

Authors:  Ana Martinez
Journal:  Med Res Rev       Date:  2008-09       Impact factor: 12.944

2.  Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation.

Authors:  Samudra K Dissanayake; Purevdorj B Olkhanud; Michael P O'Connell; Arnell Carter; Amanda D French; Tura C Camilli; Chineye D Emeche; Kyle J Hewitt; Devin T Rosenthal; Poloko D Leotlela; Michael S Wade; Sherry W Yang; Larry Brant; Brian J Nickoloff; Jane L Messina; Arya Biragyn; Keith S Hoek; Dennis D Taub; Dan L Longo; Vernon K Sondak; Stephen M Hewitt; Ashani T Weeraratna
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

3.  Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model.

Authors:  Andy J Chien; Erin C Moore; Anke S Lonsdorf; Rima M Kulikauskas; Bonnie Gould Rothberg; Aaron J Berger; Michael B Major; Sam T Hwang; David L Rimm; Randall T Moon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-14       Impact factor: 11.205

4.  Wnt5a mediates nerve growth factor-dependent axonal branching and growth in developing sympathetic neurons.

Authors:  Daniel Bodmer; Seamus Levine-Wilkinson; Alissa Richmond; Sarah Hirsh; Rejji Kuruvilla
Journal:  J Neurosci       Date:  2009-06-10       Impact factor: 6.167

5.  Loss of heterozygosity of selected tumor suppressor genes in parathyroid carcinoma.

Authors:  Linwah Yip; Raja R Seethala; Marina N Nikiforova; Yuri E Nikiforov; Jennifer B Ogilvie; Sally E Carty; John H Yim
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

6.  The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility.

Authors:  Annette Säfholm; Johanna Tuomela; Jeanette Rosenkvist; Janna Dejmek; Pirkko Härkönen; Tommy Andersson
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

7.  WNT5A expression increases during melanoma progression and correlates with outcome.

Authors:  Philip D Da Forno; J Howard Pringle; Peter Hutchinson; Joy Osborn; Qiang Huang; Linda Potter; Rachael A Hancox; Alan Fletcher; Gerald S Saldanha
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

8.  Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling.

Authors:  Richard G James; Travis L Biechele; William H Conrad; Nathan D Camp; Daniel M Fass; Michael B Major; Karen Sommer; XianHua Yi; Brian S Roberts; Michele A Cleary; William T Arthur; Michael MacCoss; David J Rawlings; Stephen J Haggarty; Randall T Moon
Journal:  Sci Signal       Date:  2009-05-26       Impact factor: 8.192

9.  Ryk cooperates with Frizzled 7 to promote Wnt11-mediated endocytosis and is essential for Xenopus laevis convergent extension movements.

Authors:  Gun-Hwa Kim; Jung-Hyun Her; Jin-Kwan Han
Journal:  J Cell Biol       Date:  2008-09-22       Impact factor: 10.539

10.  Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.

Authors:  Baozhi Chen; Michael E Dodge; Wei Tang; Jianming Lu; Zhiqiang Ma; Chih-Wei Fan; Shuguang Wei; Wayne Hao; Jessica Kilgore; Noelle S Williams; Michael G Roth; James F Amatruda; Chuo Chen; Lawrence Lum
Journal:  Nat Chem Biol       Date:  2009-01-04       Impact factor: 15.040

View more
  24 in total

Review 1.  Planar cell polarity in kidney development and disease.

Authors:  Thomas J Carroll; Amrita Das
Journal:  Organogenesis       Date:  2011-07-01       Impact factor: 2.500

Review 2.  Frizzled7 as an emerging target for cancer therapy.

Authors:  Taj D King; Wei Zhang; Mark J Suto; Yonghe Li
Journal:  Cell Signal       Date:  2011-12-13       Impact factor: 4.315

3.  Expression profile of frizzled receptors in human medulloblastomas.

Authors:  Ettore Salsano; Rosina Paterra; Miriam Figus; Francesca Menghi; Emanuela Maderna; Bianca Pollo; Carlo Lazzaro Solero; Luca Massimi; Gaetano Finocchiaro
Journal:  J Neurooncol       Date:  2011-08-18       Impact factor: 4.130

Review 4.  Lung cancer stem cells: progress and prospects.

Authors:  Amber Lundin; Barbara Driscoll
Journal:  Cancer Lett       Date:  2012-08-17       Impact factor: 8.679

5.  Molecular Signaling in Benign Odontogenic Neoplasia Pathogenesis.

Authors:  Hope M Amm; Mary MacDougall
Journal:  Curr Oral Health Rep       Date:  2016-03-31

6.  Wnt signaling in the pathogenesis of human HIV-associated pain syndromes.

Authors:  Yuqiang Shi; Jianhong Shu; Benjamin B Gelman; Joshua G Lisinicchia; Shao-Jun Tang
Journal:  J Neuroimmune Pharmacol       Date:  2013-06-05       Impact factor: 4.147

7.  Adult T-cell leukemia cells overexpress Wnt5a and promote osteoclast differentiation.

Authors:  Marcia Bellon; Nga Ling Ko; Min-Jung Lee; Yuan Yao; Thomas A Waldmann; Jane B Trepel; Christophe Nicot
Journal:  Blood       Date:  2013-05-09       Impact factor: 22.113

8.  Activation of the Wnt pathway through AR79, a GSK3β inhibitor, promotes prostate cancer growth in soft tissue and bone.

Authors:  Yuan Jiang; Jinlu Dai; Honglai Zhang; Joe L Sottnik; Jill M Keller; Katherine J Escott; Hitesh J Sanganee; Zhi Yao; Laurie K McCauley; Evan T Keller
Journal:  Mol Cancer Res       Date:  2013-10-02       Impact factor: 5.852

9.  GSK3β inhibition blocks melanoma cell/host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation.

Authors:  Jobin K John; Kim H T Paraiso; Vito W Rebecca; Liliana P Cantini; Ethan V Abel; Nicholas Pagano; Eric Meggers; Rahel Mathew; Clemens Krepler; Victoria Izumi; Bin Fang; John M Koomen; Jane L Messina; Meenhard Herlyn; Keiran S M Smalley
Journal:  J Invest Dermatol       Date:  2012-07-19       Impact factor: 8.551

10.  MiR-590-5P inhibits growth of HepG2 cells via decrease of S100A10 expression and Inhibition of the Wnt pathway.

Authors:  Xiangxiang Shan; Yufeng Miao; Rengen Fan; Haixin Qian; Ping Chen; Hongqi Liu; Xiaomei Yan; Jianping Li; Fen Zhou
Journal:  Int J Mol Sci       Date:  2013-04-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.